Oxford COVID-19 vaccine was one of the leading candidates in the corona virus vaccine race. Russia emerged victorious in the race and announced Sputnik V early and looked for collaboration from India for mass production. Meanwhile Oxford was under sharp criticism for handing over the vaccine to private player Astra Zeneca. In a setback to the trial, one individual experienced serious adverse effect, the reason for which was not known. Some news articles even speculated that the reason could be even unrelated to vaccine. The scientific community was full of praise for Oxford – Astra Zeneca and other partners for their transparency and due diligence in conducting the trials.